Авторы

  • Арипов А.Н.
  • Шокирова Г.К., Салахиддинов З.С., Юсупов К.А.

Ключевые слова:

СД 2, ХОБЛ, ХБП, Цистатин С

Библиографические ссылки

Wu L, Lan N, Yang X. Effects of empirical glucocorticoid use on severe acute exacerbation of COPD during hospitalization. //Int J Chron Obstruct Pulmon Dis. 2021; 16:2419–2431. doi:10.2147/CO PD.S300789

Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. // Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8

Jimenez D, Agusti A, Tabernero E, et al. Effect of a pulmonary embolism diagnostic strategy on clinical outcomes in patients hospitalized for COPD exacerbation: a randomized clinical trial. //JAMA. 2021;326(13):1277–1285. doi:10.1001/jama.2021. 14846

Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. //Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518

Hogea SP, Tudorache E, Fildan AP, Fira-Mladinescu O, Marc M, Oancea C. Risk factors of chronic obstructive pulmonary disease exacerbations. //Clin Respir J. 2020;14(3):183–197. doi:10.11 11/crj.13129

Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S. Determining prognosis in acute exacerbation of COPD. //Int J Chron Obstruct Pulmon Dis. 2017; 12:467–475. doi:10.2147/COPD. S122382

Rambaran K, Bhagan B, Ali A, et al. High prevalence of diabetes mellitus in a cohort of patients with chronic obstructive pulmonary disease in Trinidad, West Indies. //Turk Thorac J. 2019;20(1):12–17. doi:10.5152/TurkThoracJ.2018.18036

Castan-Abad MT, Montserrat-Capdevila J, Godoy P, et al. Diabetes as a risk factor for severe exacerbation and death in patients with COPD: a prospective cohort study. // Eur J Public Health. 2020;30(4):822–827. doi:10.1093/eurpub/ckz219

Figueira Goncalves JM, Garcia Bello MA, Golpe R, Alonso Jerez JL, Garcia-Talavera I. Impact of diabetes mellitus on the risk of severe exacerbation in patients with chronic obstructive pulmonary disease. //Clin Respir J. 2020;14(12):1208–1211. doi: 10.1111/crj.13255

Ferguson M.A., Waikar S.S. Established and emerging markers of kidney function. // Clin. Chem. 2012;58(4):680–689. Doi: 10.1373/clinchem.2011.1 67494.

Maltais F., Decramer M., Casaburi R., Barreiro E., Burelle Y., Debigaré R., et al.; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. // Am. J. Respir. Crit. Care Med. 2014;189(9): e15–e62. Doi:10.1164/rccm.201402-0373ST.

Boiko O, Rodionova V, Shevchenko L. Features of Kidney Function in Patients with Comorbidity of Arterial Hypertension and Chronic Obstructive Pulmonary Disease. Cureus. 2022 Nov 23;14(11): e31828. doi: 10.7759/cureus.31828.